CRC drivers converge on increased p-4E (S209) and p-4E-BP1(S65/T70) to promote Myc- and ISR (p-eIF2a/ATF4)-dependent adaptation and AKT activation via increased glutamine (Gln) metabolism. This evidence concerns the gene AKT1 and colorectal carcinoma.